Press What’s news at AbelsonTaylor Group
Select category
Leveraging Multi-Touch Attribution for Greater Brand Marketing Success
Even in the present age of AI, big data and omnichannel marketing, pharma brands—for the most part—are stuck to the traditional idea that the last touch, the last communication someone receives before converting, should get all, or most of the credit for that conversion. Or, they might not even know which touchpoints to attribute credit.
In her article in Muse by Clio, Rebecca Visconti, VP of Marketing Intelligence, looks beyond that conventional worship of the last touch to provide evidence-based methods to calculate the real impact of every touchpoint more accurately.
Read the full article at Muse by Clio
Media Contact:
Recent Posts
What pharma marketers should know about Bluesky
In the ever-changing world of social media, Bluesky has emerged as an intriguing new platform, particularly for HCPs and the...
In the News Read more What pharma marketers should know about BlueskyAbelsonTaylor Group Launches Pro Bono Initiative to Support Chicagoland Health and Wellness Innovators
AbelsonTaylor Group, one of the nation’s leading independent healthcare advertising agencies, is proud to announce the launch of UNITE, a...
Read Press Read more AbelsonTaylor Group Launches Pro Bono Initiative to Support Chicagoland Health and Wellness InnovatorsThink Tank – Creating the Optimal Omnichannel Media Mix
Senior Media Director Terence Prudhomme talks to PM360 Think Tank about why omnichannel marketing is more about audience data than...
In the News Read more Think Tank – Creating the Optimal Omnichannel Media MixConnect with us
Find out what's top of mind for the people reimagining health and wellness advertising.